Literature DB >> 2399336

Pituitary microadenomas: a PET study.

B De Souza1, A Brunetti, M J Fulham, R A Brooks, D DeMichele, P Cook, L Nieman, J L Doppman, E H Oldfield, G Di Chiro.   

Abstract

Twenty cases of surgically verified pituitary microadenoma (17 with Cushing disease and three with acromegaly) were studied with positron emission tomography (PET) with use of fluorine-18-2-fluorodeoxyglucose (FDG). The diagnostic results were compared with those of other modalities, namely, computed tomography (CT), magnetic resonance (MR) imaging, and, in the cases of Cushing disease, simultaneous bilateral inferior petrosal sinus sampling (SIPS). The PET results showed 12 positive readings and one questionable reading, compared with seven positive readings and one questionable reading for CT (18 cases studied) and 13 positive and two questionable MR imaging readings. PET complemented MR imaging, in the sense that five of the positive PET readings were negative or questionable at MR imaging. PET studies of 20 healthy control subjects showed no false-positive cases, whereas other studies of healthy subjects with contrast material-enhanced CT and MR imaging have yielded, respectively, 20% and 15% positive readings, with findings suggestive of silent or occult adenomas.

Entities:  

Mesh:

Year:  1990        PMID: 2399336     DOI: 10.1148/radiology.177.1.2399336

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  16 in total

1.  Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions.

Authors:  Hannah Seok; Eun Young Lee; Eun Yeong Choe; Woo In Yang; Joo Young Kim; Dong Yeob Shin; Ho Jin Cho; Tae Sung Kim; Mi Jin Yun; Jong Doo Lee; Eun Jig Lee; Sung-Kil Lim; Yumie Rhee
Journal:  Korean J Intern Med       Date:  2012-12-28       Impact factor: 2.884

Review 2.  Metabolic In Vivo Visualization of Pituitary Adenomas: a Systematic Review of Imaging Modalities.

Authors:  Amy Yao; Priti Balchandani; Raj K Shrivastava
Journal:  World Neurosurg       Date:  2017-04-28       Impact factor: 2.104

3.  11C-methionine PET for the diagnosis and management of recurrent pituitary adenomas.

Authors:  B N T Tang; M Levivier; M Heureux; D Wikler; N Massager; D Devriendt; P David; N Dumarey; B Corvilain; S Goldman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-10-15       Impact factor: 9.236

4.  High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.

Authors:  Prashant Chittiboina; Blake K Montgomery; Corina Millo; Peter Herscovitch; Russell R Lonser
Journal:  J Neurosurg       Date:  2014-12-05       Impact factor: 5.115

5.  Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre study.

Authors:  Shin Young Jeong; Sang-Woo Lee; Hui Joong Lee; Sungmin Kang; Ji-Hyoung Seo; Kyung Ah Chun; Ihn Ho Cho; Kyung Sook Won; Seok Kil Zeon; Byeong-Cheol Ahn; Jaetae Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-07-27       Impact factor: 9.236

6.  CRH stimulation improves 18F-FDG-PET detection of pituitary adenomas in Cushing's disease.

Authors:  Jacqueline Boyle; Nicholas J Patronas; James Smirniotopoulos; Peter Herscovitch; William Dieckman; Corina Millo; Dragan Maric; Grégoire P Chatain; Christina Piper Hayes; Sarah Benzo; Gretchen Scott; Nancy Edwards; Abhik Ray Chaudhury; Maya B Lodish; Susmeeta Sharma; Lynnette K Nieman; Constantine A Stratakis; Russell R Lonser; Prashant Chittiboina
Journal:  Endocrine       Date:  2019-05-06       Impact factor: 3.633

7.  The diagnostic value of fused positron emission tomography/computed tomography in the localization of adrenocorticotropin-secreting pituitary adenoma in Cushing's disease.

Authors:  Ali S Alzahrani; Rafif Farhat; Abdullah Al-Arifi; Nora Al-Kahtani; Imad Kanaan; Mohei Abouzied
Journal:  Pituitary       Date:  2009-04-22       Impact factor: 4.107

8.  In vivo manganese MR imaging of calcium influx in spontaneous rat pituitary adenoma.

Authors:  D J Cross; J A Flexman; Y Anzai; T Sasaki; P M Treuting; K R Maravilla; S Minoshima
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-09       Impact factor: 3.825

9.  Diagnostic value of 18F-dihydroxyphenylalanine positron emission tomography for growth hormone-producing pituitary adenoma.

Authors:  Takafumi Taguchi; Toshihiro Takao; Yasumasa Iwasaki; Kenichi Oyama; Shozo Yamada; Mari Inoue; Yoshio Terada
Journal:  Pituitary       Date:  2010       Impact factor: 4.107

10.  Corticotropin releasing hormone can selectively stimulate glucose uptake in corticotropinoma via glucose transporter 1.

Authors:  Jie Lu; Blake K Montgomery; Grégoire P Chatain; Alejandro Bugarini; Qi Zhang; Xiang Wang; Nancy A Edwards; Abhik Ray-Chaudhury; Marsha J Merrill; Russell R Lonser; Prashant Chittiboina
Journal:  Mol Cell Endocrinol       Date:  2017-10-03       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.